585 related articles for article (PubMed ID: 21256535)
1. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
2. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
3. Circulating microparticles and risk of venous thromboembolism.
Bucciarelli P; Martinelli I; Artoni A; Passamonti SM; Previtali E; Merati G; Tripodi A; Mannucci PM
Thromb Res; 2012 May; 129(5):591-7. PubMed ID: 21908018
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
5. Circulating procoagulant microparticles in cancer patients.
Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
[TBL] [Abstract][Full Text] [Related]
6. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
8. Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy--an observational study.
Zahra S; Anderson JA; Stirling D; Ludlam CA
Gynecol Oncol; 2011 Oct; 123(1):152-6. PubMed ID: 21777967
[TBL] [Abstract][Full Text] [Related]
9. Circulating microparticles in carriers of prothrombin G20210A mutation.
Campello E; Spiezia L; Radu CM; Gavasso S; Zerbinati P; Woodhams B; Simioni P
Thromb Haemost; 2014 Sep; 112(3):432-7. PubMed ID: 24816676
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tissue factor bearing microparticles as biomarkers in allogeneic stem-cell transplantation.
De Rop C; Stadler M; Buchholz S; Eisert R; Ganser A; Trummer A
Transplantation; 2011 Aug; 92(3):351-8. PubMed ID: 21681142
[TBL] [Abstract][Full Text] [Related]
11. Involvement of microparticles in diabetic vascular complications.
Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
[TBL] [Abstract][Full Text] [Related]
12. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
13. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients.
Thaler J; Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):127-31. PubMed ID: 21792463
[TBL] [Abstract][Full Text] [Related]
15. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
16. Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head.
Kang P; Shen B; Yang J; Pei F
Thromb Res; 2008; 123(2):367-73. PubMed ID: 18495220
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty.
Johnson GJ; Leis LA; Bach RR
Thromb Haemost; 2009 Oct; 102(4):728-34. PubMed ID: 19806259
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.
Delluc A; Rousseau A; Delluc C; Le Moigne E; Le Gal G; Mottier D; Van Dreden P; Lacut K
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):295-300. PubMed ID: 21372691
[TBL] [Abstract][Full Text] [Related]
19. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
[TBL] [Abstract][Full Text] [Related]
20. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation.
Stępień E; Stankiewicz E; Zalewski J; Godlewski J; Zmudka K; Wybrańska I
Arch Med Res; 2012 Jan; 43(1):31-5. PubMed ID: 22306248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
